The ALK inhibitors, alectinib and ceritinib, induce ALK‐independent and STAT3‐dependent glioblastoma cell death
2021 · Cancer Science · 13 citations
https://doi.org/10.1111/cas.14885
Nihon University(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
58
Papers
316
Citations
12
h-index
13
i10-index
Shun Yamamuro is an academic researcher from Nihon University. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Pituitary Gland Disorders and Treatments & Meningioma and schwannoma management. The author has an h-index of 12, co-authored 50 publications.
ORCID: 0000-0003-0439-9277https://doi.org/10.1111/cas.14885
https://doi.org/10.1016/j.heliyon.2025.e43167
https://doi.org/10.1016/j.inat.2021.101149
https://doi.org/10.1016/j.inat.2021.101196
Click to start Chat